Zoetis (NYSE:ZTS)

HillCountryDungn (< 20) Submitted: 6/2/2013 11:15:18 PM : Start Price: $32.01 ZTS Score: -3.51

Sales growth is expanding fast, and spinoff from Pfizer should enhance economics.

ScubaSteveO (58.38) Submitted: 5/30/2013 7:43:49 AM : Start Price: $34.25 ZTS Score: -8.91

Zoetis has been the largest developer and manufacturer of veterinary vaccines and medicines and is the largest publicly traded animal health company; not a new company, but a recent spinoff from Pfizer. Zoetis is diversified in 120 different countries, with manufacturing facilities in 11 different countries and develops products specific to different areas of concerns geographically.

Revenue up 7% growth; both revenues in livestock and companion animals are up from a year ago, as well as 8% growth in earnings in the U.S. alone. First quarter up 4% in revenue and 26% in net income. One of their biggest products (Convenia), which is a one-time injection used to fight skin infections in cats and dogs was launched in China this March and is now available in 50 countries. They project an approx. $1 increase to EPS this year which includes the costs associated from its separation from Pfizer; it’s already up $1.89 per share from its initial price in Feb.

I believe Zoetis is prepared to stand on its own and is poised to succeed and have made it one of my own investments.

toegar2000 (61.41) Submitted: 3/2/2013 10:23:54 AM : Start Price: $34.73 ZTS Score: -19.15

Strong product line.

SoMch2Knw (87.71) Submitted: 2/19/2013 1:19:58 PM : Start Price: $33.69 ZTS Score: -15.56

Pfizer spin-off of animal care unit...

http://stockcharts.com/freecharts/gallery.html?ZTS

...should be an interesting development.

AFoolRushesIn (< 20) Submitted: 2/7/2013 2:53:30 PM : Start Price: $32.00 ZTS Score: -12.16

Pfizer seperating the animal health side of the business from the human side is a smart move.

InvestorDeb (71.61) Submitted: 2/4/2013 3:00:32 PM : Start Price: $31.51 ZTS Score: -11.23

The largest standalone company fully devoted to animal health medicines and vaccines spun off from Pfizer on Friday. Animal health is a strengthening and growing market, and Zoetis is uniquely positioned to benefit from that growth. I put 1/4 of a position on today, and will look to be opportunistic to add to it.

chopchop0 (47.73) Submitted: 2/1/2013 3:50:45 PM : Start Price: $31.15 ZTS Score: -9.25

The first publicly-traded "pure play" animal health sciences company should do well over the long-term.